{"id":"https://openalex.org/W2005237753","doi":"https://doi.org/10.2174/187152408783790596","title":"Design and Evaluation of Semicarbazones and Thiosemicarbazones as Novel Anticonvulsants","display_name":"Design and Evaluation of Semicarbazones and Thiosemicarbazones as Novel Anticonvulsants","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2005237753","doi":"https://doi.org/10.2174/187152408783790596","mag":"2005237753"},"language":"en","primary_location":{"id":"doi:10.2174/187152408783790596","doi":"https://doi.org/10.2174/187152408783790596","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152408783790596","pdf_url":null,"source":{"id":"https://openalex.org/S2765063124","display_name":"Central Nervous System Agents in Medicinal Chemistry","issn_l":"1568-0150","issn":["1568-0150","1871-5249","1875-6158","1875-6166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Central Nervous System Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Navneet Aggarwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Navneet Aggarwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087203151","display_name":"Ruchi Aggarwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruchi Aggarwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050659598","display_name":"Pradeep Mishra","orcid":"https://orcid.org/0000-0002-2452-1869","observed_orcids":["https://orcid.org/0000-0002-2452-1869"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pradeep Mishra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000730866","display_name":"Jainendra Jain","orcid":"https://orcid.org/0000-0001-5272-3567","observed_orcids":["https://orcid.org/0000-0001-5272-3567"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. Jain","raw_affiliation_strings":["Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut,Uttar Pradesh-250005, India.,India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut,Uttar Pradesh-250005, India.,India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109812350","display_name":"S. Bansal","orcid":"https://orcid.org/0009-0009-5224-9987","observed_orcids":["https://orcid.org/0009-0009-5224-9987"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Bansal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"K. Jha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"K. Jha","raw_affiliation_strings":["Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut,Uttar Pradesh-250005, India.,India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut,Uttar Pradesh-250005, India.,India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5000730866"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2169,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.59558605,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"8","issue":"1","first_page":"26","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8101000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8101000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.15309999883174896,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13876","display_name":"Chemical synthesis and pharmacological studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semicarbazones","display_name":"semicarbazones","score":0.9980000257492065},{"id":"https://openalex.org/keywords/thiosemicarbazones","display_name":"thiosemicarbazones","score":1.0},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9539999961853027},{"id":"https://openalex.org/keywords/seizure-activity","display_name":"seizure activity","score":0.5820000171661377},{"id":"https://openalex.org/keywords/citral","display_name":"citral","score":0.8519999980926514},{"id":"https://openalex.org/keywords/carvone","display_name":"carvone","score":1.0},{"id":"https://openalex.org/keywords/levulinic-acid","display_name":"levulinic acid","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lipophilic-substituents","display_name":"lipophilic substituents","score":0.8230000138282776},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.800000011920929},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.5370000004768372},{"id":"https://openalex.org/keywords/maximal-electroshock-test","display_name":"maximal electroshock test","score":0.7730000019073486},{"id":"https://openalex.org/keywords/metrazol-induced-seizures","display_name":"metrazol-induced seizures","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C83591994","wikidata":"https://www.wikidata.org/wiki/Q416105","display_name":"Semicarbazone","level":2,"score":0.9436981678009033},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7662841081619263},{"id":"https://openalex.org/C2781370763","wikidata":"https://www.wikidata.org/wiki/Q60176530","display_name":"Citral","level":3,"score":0.6988649964332581},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.6476125717163086},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.5493618249893188},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.451741486787796},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.41079992055892944},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.20981478691101074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17563802003860474},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.14069339632987976},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.10196992754936218},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C2777278459","wikidata":"https://www.wikidata.org/wiki/Q170885","display_name":"Essential oil","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/187152408783790596","doi":"https://doi.org/10.2174/187152408783790596","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152408783790596","pdf_url":null,"source":{"id":"https://openalex.org/S2765063124","display_name":"Central Nervous System Agents in Medicinal Chemistry","issn_l":"1568-0150","issn":["1568-0150","1871-5249","1875-6158","1875-6166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Central Nervous System Agents in Medicinal Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2183175637","https://openalex.org/W2272955781","https://openalex.org/W1975634374","https://openalex.org/W1971605869","https://openalex.org/W1988846902","https://openalex.org/W1972652050","https://openalex.org/W4285274844","https://openalex.org/W2104095503","https://openalex.org/W2952321839","https://openalex.org/W2066785015"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,56,70,79],"semicarbazones":[3],"and":[4,8,37,44,54,61,68],"thiosemicarbazones":[5,55,106],"were":[6,22,73],"designed":[7],"synthesized":[9],"to":[10,31,75],"meet":[11],"the":[12,20,80],"structural":[13],"requirements":[14],"essential":[15],"for":[16,24],"anticonvulsant":[17,25],"activity.":[18],"All":[19],"compounds":[21],"evaluated":[23],"activity":[26,65],"after":[27],"intraperitoneal":[28],"(i.p.)":[29],"administration":[30],"mice":[32],"by":[33,50],"maximal":[34],"electroshock":[35],"(MES)":[36],"subcutaneous":[38],"metrazol":[39],"(ScMet)":[40],"induced":[41],"seizure":[42],"methods":[43],"minimal":[45],"motor":[46],"impairment":[47],"was":[48],"determined":[49],"rotorod":[51],"test.":[52],"Semicarbazones":[53],"lipophillic":[57,93],"carbonyl":[58],"groups":[59,94],"(citral":[60],"carvone)":[62],"showed":[63],"excellent":[64],"while":[66],"semicarbazone":[67],"thiosemicarbazone":[69],"levulinic":[71],"acid":[72],"found":[74],"be":[76,89,98],"inactive.":[77],"Results":[78],"present":[81],"study":[82],"show":[83],"that":[84],"lipophilic":[85],"aryl":[86],"ring":[87],"could":[88,96],"replaced":[90,99],"with":[91,100],"non-cyclic":[92],"but":[95],"not":[97],"hydrophilic":[101],"substituents.":[102],"Keywords:":[103],"Anticonvulsant,":[104],"semicarbazones,":[105]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}